Reference notes for new COVID-19 diagnostics

New molecular diagnostic tests to diagnose COVID-19 caused by SARS-CoV-2 infection have been added to UNICEF Supply Catalogue.

A COVID-19 coronavirus test kit, during a press conference at the Ministry of Science and Technology in Taipei on April 8, 2020.
NICEF/UNI325481/Yeh/AFP

About

New molecular tests for COVID-19 diagnosis have been added to UNICEF diagnostics portfolio and are now available for UNICEF programme countries and procurement services partners in addition to automated real-time PCR tests. Like all COVID-19 diagnostics procured by Supply Division, new products are quality-assured, i.e. either listed under the WHO Emergency Use List (EUL) or holding the FDA Emergency Use Authorization (EUA).

The new molecular tests for COVID-19 diagnosis are compatible with some of the most popular types of PCR platforms that are widely available in the supported countries. Importantly, the new COVID-19 diagnostics are available with very short FCA lead times – some within 1 week only – which is critical for countries struggling with COVID-19 supply shortages and interruptions.

Product reference notes for all new COVID-19 diagnostics are available and useful for evaluators and decision-makers. The notes include comprehensive technical and commercial information, such as kit contents, compatible extraction kits, PCR equipment and software, as well as price and indicative lead time.

Download the notes by selecting each of them on the dropdown menu.

Download document

(PDF, 214,63 KB) (PDF, 201,16 KB) (PDF, 160,29 KB) (PDF, 204,05 KB) (PDF, 272,55 KB) (PDF, 152,45 KB) (PDF, 314,93 KB) (PDF, 72,66 KB) (PDF, 746,88 KB)